REVOLUTION Medicines

RVMD48

$47.75arrow_drop_down5.31%-$2.67

RVMD48

$47.75

arrow_drop_down5.31%-$2.67

Performance History

Key Stats
Open	$50.10
Prev. Close	$50.00
EPS	-3.72
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	47.74	51.70
52 Week Range	15.44	48.61

Ratios







EPS	-3.72

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About REVOLUTION Medicines (RVMD)

REVOLUTION Medicines Inc (RVMD) is a biotechnology company focused on developing transformative small molecule drugs that target the root cause of cancer. The company's proprietary platform combines cutting-edge computational tools with a deep understanding of cancer biology to identify and design drugs that selectively target specific cancer-causing proteins. By targeting the driver mutations that initiate and promote cancer growth, REVOLUTION Medicines aims to deliver precision therapies that can effectively treat a wide range of cancers.

With a strong emphasis on scientific innovation, REVOLUTION Medicines is constantly pushing the boundaries of drug discovery and development. The company's team of experienced scientists and researchers leverage their expertise in biochemistry, structural biology, and medicinal chemistry to design novel compounds with enhanced drug-like properties. By harnessing the power of rational drug design, REVOLUTION Medicines is able to accelerate the development of potential life-saving therapies.

Investors in REVOLUTION Medicines can benefit from the company's strong market position and promising pipeline. REVOLUTION Medicines has built a robust portfolio of drug candidates, with multiple programs in clinical development. These candidates target key cancer-causing proteins, such as RAS and mTOR, which have been historically challenging to drug. By addressing these unmet medical needs, REVOLUTION Medicines has the potential to revolutionize cancer treatment and create significant value for its shareholders.

As of the latest available information, REVOLUTION Medicines has a market capitalization of approximately $X billion. This reflects the market's confidence in the company's ability to successfully develop and commercialize its drug candidates. The market cap is calculated by multiplying the company's current share price by the total number of outstanding shares.

In addition to its market cap, investors may also consider the PEG ratio when evaluating REVOLUTION Medicines as an investment opportunity. The PEG ratio is a valuation metric that takes into account a company's expected earnings growth rate. A PEG ratio below 1 may indicate that a stock is undervalued, while a PEG ratio above 1 may suggest that a stock is overvalued. It is important to note that the PEG ratio should be used in conjunction with other financial metrics to make informed investment decisions.

When comparing REVOLUTION Medicines to its industry peers, it is important to consider factors such as market share, revenue growth, and pipeline strength. REVOLUTION Medicines operates in the biotechnology sector, which is known for its high-growth potential but also significant competition. By evaluating REVOLUTION Medicines' performance relative to its industry, investors can gain insights into the company's competitive position and growth prospects.

Over the past 52 weeks, REVOLUTION Medicines' stock has traded within a range of $X to $X. This indicates the highest and lowest prices at which the stock has traded over the past year. The 52-week range can provide investors with a sense of the stock's volatility and potential upside or downside.

On the most recent trading day, REVOLUTION Medicines' stock had a day range of $X to $X. This represents the range of prices at which the stock traded during that particular day. The day range can be useful for short-term traders who are looking to capitalize on intraday price fluctuations.

Finally, investors may consider the trading volume of REVOLUTION Medicines' stock. Trading volume refers to the total number of shares that were bought and sold during a given period. Higher trading volume can indicate increased investor interest and liquidity in the stock. It is important to keep in mind that trading volume should be used in conjunction with other metrics to make well-informed investment decisions.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Mark A. Goldsmith Ph.D.
Headquarters: Redwood City
Employees: 292
Exchange: NASDAQ

Keep an eye on REVOLUTION Medicines

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is the 52-week high and low for REVOLUTION Medicines (RVMD)?

For REVOLUTION Medicines (RVMD), the 52-week high is $48.61, which is 1.8% from the current price. The 52-week low is $15.44, the current price is 209.26% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is REVOLUTION Medicines (RVMD) a growth stock?

REVOLUTION Medicines (RVMD) has shown an average price growth of -2.03% over the past three years. It has received a score of 87 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying REVOLUTION Medicines as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is REVOLUTION Medicines 's (RVMD) price per share?

The current price per share for REVOLUTION Medicines (RVMD) is $47.75. The stock has seen a price change of -$2.68 recently, indicating a -5.31% change. This reflects the stock's recent market performance and investor sentiment.

help

What is REVOLUTION Medicines (RVMD) stock price performance year to date (YTD)?

As of the latest data, REVOLUTION Medicines (RVMD) has a year-to-date price change of 69.15%. Over the past month, the stock has experienced a price change of 12.01%. Over the last three months, the change has been -0.4%. Over the past six months, the figure is 31.07%.

help

Is REVOLUTION Medicines (RVMD) a profitable company?

REVOLUTION Medicines (RVMD) has a net income of -$436.37M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 19.61% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -77.52K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $11.58M, although specific revenue growth data is currently not available. The gross profit is $2.27M. Operating income is noted at -$487.18M. Furthermore, the EBITDA is -$569.47M.

help

What is the market capitalization of REVOLUTION Medicines (RVMD)?

REVOLUTION Medicines (RVMD) has a market capitalization of $8.42B. The average daily trading volume is 48.46, indicating the stock's liquidity and investor engagement.